Keywords: داریفناسین; Vejiga hiperactiva; Darifenacina; Estimulación del nervio tibial posteriorOveractive bladder; Darifenacin; Posterior tibial nerve stimulation
مقالات ISI داریفناسین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: داریفناسین; Darifenacin; HPLC; Method of validation; Mouse plasma; Pharmacokinetic study;
Keywords: داریفناسین; Puerariae lobatae Radix; Gegen; Detrusor overactivity; Darifenacin; Synergism; Spontaneously hypertensive ratCI, combination index; EFS, electrical field stimulation; High_Dar, darifenacin, 30 mg/kg; Low_Dar, darifenacin, 3 mg/kg; SHR, spontaneously hyper
Evaluating the effect of three newly approved overactive bladder syndrome treating agents on parotid and submandibular salivary glands: Modulation of CXCL10 expression
Keywords: داریفناسین; Oxybutynin; Trospium; Darifenacin; Solifenacin; Salivary glands;
Effects of modulating M3 muscarinic receptor activity on azoxymethane-induced liver injury in mice
Keywords: داریفناسین; Liver injury; Muscarinic receptors; Pilocarpine; Darifenacin; Azoxymethane
A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder
Keywords: داریفناسین; Overactive bladder; Urgency frequency syndrome; Detrusor overactivity; Muscarinic receptor antagonist; Darifenacin; Emepronium; Fesoterodine; Oxybutynin; Propantheline; Propiverine; Solifenacin; Tolterodine; Trospium
Effect of antimuscarinic drugs used for overactive bladder on learning in a rat passive avoidance response test
Keywords: داریفناسین; Antimuscarinic drug; Darifenacin; Oxybutynin; Propiverine; Solifenacin; Tolterodine; Learning; Passive avoidance task
Effects of the M3 Receptor Selective Muscarinic Antagonist Darifenacin on Bladder Afferent Activity of the Rat Pelvic Nerve
Keywords: داریفناسین; Bladder; Neurons; Afferent; Rats; Sprague-Dawley; Muscarinic antagonists; Darifenacin
In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice
Keywords: داریفناسین; Darifenacin; Overactive bladder; Bladder; Submaxillary gland; M3 muscarinic receptor binding; Salivary secretion
Anticholinergic Drugs in Patients with Bladder Outlet Obstruction and Lower Urinary Tract Symptoms: A Systematic Review
Keywords: داریفناسین; α-Blockers; Anticholinergic drugs; Antimuscarinics; Benign prostatic hyperplasia; Bladder outlet obstruction; Darifenacin; LUTS; Overactive syndrome; Oxybutynin; Solifenacin; Tolterodine
Differential Effects of the Antimuscarinic Agents Darifenacin and Oxybutynin ER on Memory in Older Subjects
Keywords: داریفناسین; Cognitive function; Darifenacin; Antimuscarinic; Older subjects; Oxybutynin ER
INCREASED WARNING TIME WITH DARIFENACIN: A NEW CONCEPT IN THE MANAGEMENT OF URINARY URGENCY
Keywords: داریفناسین; bladder; urination disorders; darifenacin; urinary incontinence;
ASSESSMENT OF COGNITIVE FUNCTION OF THE ELDERLY POPULATION: EFFECTS OF DARIFENACIN
Keywords: داریفناسین; bladder; aged; darifenacin; neurobehavioral manifestations; receptors, muscarinic;
Treatment of Overactive Bladder in the Older Patient: Pooled Analysis of Three Phase III Studies of Darifenacin, an M3 Selective Receptor Antagonist
Keywords: داریفناسین; Darifenacin; Elderly; Overactive bladder; Urinary incontinence;
Comparison of Darifenacin and Oxybutynin in Patients with Overactive Bladder: Assessment of Ambulatory Urodynamics and Impact on Salivary Flow
Keywords: داریفناسین; Darifenacin; Heart rate; Oxybutynin; Overactive bladder; Salivary flow; Urodynamics;
The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis
Keywords: داریفناسین; (A); trial published in abstract form only; AE; any adverse event; ANMF; the number of patients achieving normal micturition frequency; ASAE; any serious adverse event; BOO; bladder outlet obstruction; CCT; Controlled Clinical Trial; CCTR; Cochrane Contro